Document is current
Any future updates will be listed below
-
Authors
Nguyen, Michelle-Linh T. https://orcid.org/0000-0002-3470-0713
Garcia, Faviola
Juarez, Jennifer
Zeng, Billy
Khoong, Elaine C.
Nijagal, Malini A.
Sarkar, Urmimala
Su, George
Lyles, Courtney R.
-
Funding
Funding for this research was provided by:
Genentech (UCSF/Genentech Mid-Career Development Award)
Health Resources and Services Administration (NRSA T32HP19025)
National Cancer Institute (K24CA212294)
National Heart, Lung, and Blood Institute (K12HL138046)
National Center for Advancing Translational Sciences (KL2TR001870)
Patrick and Catherine Weldon Donaghue Medical Research Foundation
- License Information
-
More Information
Article History
Received: 28 September 2021
Accepted: 25 January 2022
First Online: 14 February 2022
Declarations
:
: Verbal consent was obtained from all participants because the study procedures presented no more than minimal risk of harm. This project was categorized as quality improvement and determined to be exempt from Institutional Review Board review by Western Institutional Review Board (#1-1261001-1).
: Not applicable
: Michelle-Linh T. Nguyen owns shares of the company, Doximity, which provides telemedicine services. She purchased these shares after data analysis for this study had ended.
